hims wegovy - Search News

Novo Nordisk, Hims

Hims & Hers stock skyrockets 40% as Novo Nordisk ends feud, agrees to sell Ozempic and Wegovy on platform

Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.

· 19h

Novo Nordisk deal lets Hims sell Wegovy and Ozempic, drops lawsuit

· 1d · on MSN

Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?

· 1d

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic

Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic drugs through U.S. telehealth company Hims & Hers' platform, the Danish drugmaker said on Monday, ending a legal dispute that erupted...

· 1d

Hims & Hers Stock Surges as Novo Nordisk Deal Ends Legal Dispute

· 1d

Hims & Hers stock price soars following weight loss drug deal

Hims & Hers shares surge after Novo Nordisk drops patent infringement case over compounded weight loss drugs

Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.

1don MSN

Hims & Hers abandons plan for cheaper Wegovy knockoff after FDA warning

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug